Aktuelle Publikationen aus 2010 - 2014

Hier sind die nationalen und internationalen Fachpublikationen der Mitglieder des Kompetenznetzes Demenzen e.V. in Form einer bibliografischen Liste aufgeführt. Die Sortierung erfolgt alphabetisch. Die Titel der Texte sind je mit einem Abstract zur Ansicht verlinkt.

 

(diese Seite wird momentan aktualisiert)

-A-

Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J:

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2010; 29(5): 448-56.

Alexopoulos P, Kurz A, Lewczuk P, Kornhuber J, Wiltfang J, Maier W, Förstl H, Perneczky R:

The sortilin-related receptor SORL1 and the amyloid cascade: a possible explanation for the concurrent elevation of CSF soluble APPalpha and APPbeta in Alzheimer's disease. Int J Geriatr Psychiatry. 2010; 25(5): 542-3.

Alexopoulos P, Topalidis S, Irmisch G, Prehn K, Jung SU, Poppe K, Sebb H, Perneczky R, Kurz A, Bleich S, Herpertz SC:

Homocysteine and cognitive function in geriatric depression. Neuropsychobiology. 2010; 61(2): 97-104.

nach oben

-B-

Bacher M, Deuster O, Aljabari B, Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y, Dodel R:

The role of macrophage migration inhibitory factor in Alzheimer's disease. Mol Med. 2010 ; 16(3-4): 116-21.

Bergfield KL, Hanson KD, Chen K, Teipel SJ, Hampel H, Rapoport SI, Moeller JR, Alexander GE:

Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. Neuroimage. 2010; 49(2): 1750-9.

Bibl M, Esselmann H, Lewczuk P, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J, Mollenhauer B:

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia. Int J Alzheimers Dis. 2010; Article ID 761571

Blennow K, Hampel H, Weiner M, Zetterberg H:

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010; 6(3): 131-44.

Bokde AL, Karmann M, Born C, Teipel SJ, Omerovic M, Ewers M, Frodl T, Meisenzahl E, Reiser M, Möller HJ, Hampel H:

Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment. J Alzheimers Dis. 2010; 21(1): 103-18.

Bokde AL, Lopez-Bayo P, Born C, Ewers M, Meindl T, Teipel SJ, Faltraco F, Reiser MF, Möller HJ, Hampel H:

Alzheimer disease: functional abnormalities in the dorsal visual pathway. Radiology. 2010; 254(1): 219-26.

Buschert V, Bokde AL, Hampel H:

Cognitive intervention in Alzheimer disease. Nat Rev Neurol. 2010; 6(9): 508-17.

nach oben

-C-

Corneveaux J, Liang WS, Reiman EM, Webster J, Myers AJ, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Craig DW, Coon KD, Dunckley T, Bandy D, Lee W, Chen K, Beach TG, Mastroeni D, Grover A, Ravid R, Sando SB, Aasly JO, Heun R, Jessen F, Kölsch H et al

Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging. 2010; 31(6): 901-9.

nach oben

-D-

Dietl M, Kornhuber J, Schöffski O, Grässel E:

Kosteneffektivitätsmodell eines ambulanten Hilfeangebotes für pflegende Angehörige von Demenzkranken. Gesundheitswesen. 2010; 72(2): 99-105.

Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y et al

Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010; Epub ahead of print

nach oben

-E-

Ebert S, Goos M, Rollwagen L, Baake D, Zech WD, Esselmann H, Wiltfang J, Mollenhauer B, Schliebs R, Gerber J, Nau R:

Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases. J Neurosci Res. 2010; 88(5): 1124-36.

Eisele M, van den Bussche H, Koller D, Wiese B, Kaduszkiewicz H, Maier W, Glaeske G, Steinmann S, Wegscheider K, Schön G:

Utilization patterns of ambulatory medical care before and after the diagnosis of dementia in Germany--results of a case-control study. Dement Geriatr Cogn Disord. 2010; 29(6): 475-83.

Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T:

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease. CNS Neurosci Ther. 2010; 16(4): 246-53.

Ernst A, Buerger K, Hartmann O, Dodel R, Noelker C, Sommer N, Schwarz M, Köhrle J, Bergmann A, Hampel H:

Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation. J Neuroimmunol. 2010; 221(1-2): 62-7.

Ewers M, Cheng X, Nural HF, Walsh C, Meindl T, Teipel SJ, Buerger K, Shen Y, Hampel H:

Increased CSF- BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease. J Alzheimers Dis. 2010; Epub ahead of print

Ewers M, Mielke MM, Hampel H:

Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol. 2010; 45(1): 75-9.

nach oben
nach oben

-G-

Grimmer T, Tholen S, Yousefi BH, Alexopoulos P, Förschler A, Förstl H, Henriksen G, Klunk WE, Mathis CA, Perneczky R, Sorg C, Kurz A, Drzezga A:

Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E epsilon4 Genotype in Alzheimer's Disease. Biol Psychiatry. 2010; Epub ahead of print

nach oben

-H-

Haberstroh J, Hampel H, Pantel J:

Optimal management of Alzheimer's disease patients: Clinical guidelines and family advice. Neuropsychiatr Dis Treat. 2010; 6: 243-53.

Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ:

Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol. 2010; 45(1): 30-40.

Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K:

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010; 9(7): 560-74.

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K:

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp Neurol. 2010; 223(2): 334-46.

Hausner L, Frölich L, Gardette V, Reynish E, Ousset PJ, Andrieu S, Vellas B, On Behalf Of The Ictus-Eadc Study Group:

Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: data from the ICTUS study. J Alzheimers Dis. 2010; 21(1): 155-65.

Heun R, Gühne U, Luck T, Angermeyer MC, Ueberham U, Potluri R, Natalwala A, Arendt T, Riedel-Heller SG:

Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment. Eur Psychiatry. 2010; 25(1): 15-8.

Hoffmann F, van den Bussche H, Glaeske G, Kaduszkiewicz H:

Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany. Int Clin Psychopharmacol. 2010 Jan; 25(1): 29-36.

Hüll M, Wernher I:

Psychosoziale Interventionen und Angehörigenverfahren. Nervenarzt. 2010; 81(7): 823-6.

nach oben

-J-

Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, van de Pol L, Scheltens P, Tan FE, Jolles J, Verhey FR:

The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2010; Epub ahead of print

Jessen F, Kaduszkiewicz H, Daerr M, Bickel H, Pentzek M, Riedel-Heller S, Wagner M, Weyerer S, Wiese B, van den Bussche H, Broich K, Maier W:

Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci. 2010 Oct 20; Epub ahead of print

Jessen F, Spottke A:

Therapie von psychischen und Verhaltenssymptomen bei Demenz. Nervenarzt. 2010; 81(7): 815-822.

Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, Kölsch H, Luck T, Mösch E, van den Bussche H, Wagner M, Wollny A, Zimmermann T, Pentzek M, Riedel-Heller SG, Romberg HP, Weyerer S, Kaduszkiewicz H, Maier W, Bickel H; German Study on Aging:

Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010; 67(4): 414-22.

Jessen F:

Stellungnahme zur S3-Leitlinie Demenzen der DGPPN und der DGN aus psychiatrischer Sicht. Fortschr Neurol Psychiatr. 2010; 78(9): 509-12.

nach oben

-K-

Kaduszkiewicz H, Zimmermann T, Van den Bussche H, Bachmann C, Wiese B, Bickel H, Mösch E, Romberg HP, Jessen F, Cvetanovska-Pllashniku G, Maier W, Riedel-Heller SG, Luppa M, Sandholzer H, Weyerer S, Mayer M, Hofmann A, Fuchs A, Abholz HH, Pentzek M;AgeCoD

Do general practitioners recognize mild cognitive impairment in their patients? J Nutr Health Aging. 2010; 14(8): 697-702.

Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T:

Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease. Neurobiol Aging. 2010 Jun; Epub ahead of print

Koch W, Teipel S, Mueller S, Buerger K, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T:

Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter? Neuroimage. 2010; 51(1): 280-7.

Kölsch H, Heun R, Jessen F, Popp J, Hentschel F, Maier W, Lütjohann D:

Alterations of cholesterol precursor levels in Alzheimer's disease. Biochim Biophys Acta. 2010; 1801(8): 945-50.

Kornhuber J, Thürauf N, Lewczuk P:

Welche Eigenschaften soll ein Marker für die Früh- und Differenzialdiagnostik neurodegenerativer Erkrankungen haben? Fortschr Neurol Psychiatr. 2010; 78(8): 443-4.

Kurz A, Perneczky R:

Novel insights for the treatment of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010; Epub ahead of print

nach oben

-L-

Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus Ch, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H et al

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry 2010; 15(2): 138-45.

Lewczuk P, Kornhuber J, Vanmechelen E, Peters O, Heuser I, Maier W, Jessen F, Bürger K, Hampel H, Frölich L, Henn F, Falkai P, Rüther E, Jahn H, Luckhaus Ch, Perneczky R, Schmidtke K, Schröder J, Kessler H, Pantel J, Gertz HJ, Vanderstichele H, de Meye

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol. 2010; 223(2): 366-70.

Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, Martínez-Lage P, Monsch AU, Tsolaki M, van Laar T:

Turning principles into practice in Alzheimer's disease. Int J Clin Pract. 2010; 64(9): 1198-209.

Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kölsch H, Weller M, Jessen F:

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease. Neurodegener Dis. 2010; Epub ahead of print

Lucignani G, Perneczky R:

Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis. Eur J Nucl Med Mol Imaging. 2010; 37(2): 399-404.

Luck T, Luppa M, Angermeyer MC, Villringer A, König HH, Riedel-Heller SG:

Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: results of the Leipzig Longitudinal Study of the Aged. Psychol Med. 2010;  29: 1-11.

Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ:

The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res. 2010; 183(1): 44-51.

Luckhaus C, Jänner M, Cohnen M, Flüß MO, Teipel SJ, Grothe M, Hampel H, Kornhuber J, Rüther E, Peters O, Supprian T, Gaebel W, Mödder U, Wittsack HJ:

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables. Eur J Neurol; Epub ahead of print

Luppa M, Gentzsch K, Angermeyer MC, Weyerer S, König HH, Riedel-Heller SG:

Gender-Specific Predictors of Institutionalisation in the Elderly - Results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Psychiatr Prax. 2010; Epub ahead of print

Luppa M, Luck T, Weyerer S, König HH, Brähler E, Riedel-Heller SG:

Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010; 39(1): 31-8.

nach oben

-M-

Maier W, Jessen F:

Evidenzbasierte Standards für die Versorgung von Patienten mit Demenzen. Die interdisziplinäre S3-Leitlinie „Demenzen". Nervenarzt. 2010; 81(7): 795.

Martinez-Lage P, Frolich L, Knox S, Berthet K:

Assessing physician attitudes and perceptions of Alzheimer's disease across Europe. J Nutr Health Aging. 2010; 14(7): 537-44.

Metternich B, Kosch D, Kriston L, Härter M, Hüll M:

The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom. 2010; 79(1): 6-19.

Metternich B, Schmidtke K, Härter M, Dykierek P, Hüll M:

Konzeption und Erprobung eines gruppentherapeutischen Behandlungskonzepts für die funktionelle Gedächtnis- und Konzentrationsstörung. Psychother Psychosom Med Psychol. 2010; 60(6): 202-10.

Mohamadi MR, Svobodova Z, Verpillot R, Esselmann H, Wiltfang J, Otto M, Taverna M, Bilkova Z, Viovy JL:

Microchip electrophoresis profiling of Aβ peptides in the cerebrospinal fluid of patients with Alzheimer's disease. Anal Chem. 2010; 82(18): 7611-7.

Muth K, Schönmeyer R, Matura S, Haenschel C, Schröder J, Pantel J:

Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region. Biol Psychiatry. 2010; 67(6): 588-91.

Müther J, Abholz HH, Wiese B, Fuchs A, Wollny A, Pentzek M:

Are patients with dementia treated as well as patients without dementia for hypertension, diabetes, and hyperlipidaemia? Br J Gen Pract. 2010; 60(578): 671-4.

nach oben

-P-

Pentzek M, Fuchs A, Abholz HH, Wollny A:

Awareness of local dementia services among general practitioners with an academic affiliation. Aging Clin Exp Res. 2010; Epub ahead of print

Pentzek M, Fuchs A, Wiese B, Abholz HH:

Which Information do GPs Use to Rate the Cognitive Status of Elderly Non-Demented Patients? Psychiatr Prax. 2010; Epub ahead of print

Perneczky R, Alexopoulos P, Schmid G, Sorg C, Förstl H, Diehl-Schmid J, Kurz A:

Kognitive Reservekapazität und ihre Bedeutung für Auftreten und Verlauf der Demenz. Nervenarzt. 2010; Epub ahead of print

Perneczky R, Drzezga A, Boecker H, Ceballos-Baumann AO, Valet M, Feurer R, Förstl H, Kurz A, Häussermann P:

Metabolic alterations associated with impaired clock drawing in Lewy body dementia. Psychiatry Res. 2010; 181(2): 85-9.

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group:

Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease. Neurology. 2010; 75(2): 137-42.

Plant C, Teipel SJ, Oswald A, Böhm C, Meindl T, Mourao-Miranda J, Bokde AW, Hampel H, Ewers M:

Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage. 2010; 50(1): 162-74.

Popp J, Lewczuk P, Frommann I, Kölsch H, Kornhuber J, Maier W, Jessen F:

Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEpsiε4 Genotype. J Alzheimers Dis. 2010; Epub ahead of print

Prvulovic D, Hampel H, Pantel J:

Galantamine for Alzheimer's disease. Expert Opin Drug Metab Toxicol. 2010; 6(3): 345-54.

Puetz J, Grohmann S, Metternich B, Kloepfer C, Feige B, Nissen C, Riemann D, Hüll M, Hornyak M:

Impaired memory consolidation during sleep in patients with functional memory disorder. Biol Psychol. 2010 Oct 15; Epub ahead of print

nach oben
nach oben

-S-

Schmidt D, Zimmermann R, Lewczuk P, Schaller G, Degirmenci U, Kreil S, Wiltfang J, Kuwert T, Kornhuber J, Weih M:

Confirmation rate of blinded (99m)Tc-SPECT compared to neurochemical dementia biomarkers in CSF in patients with Alzheimer disease. J Neural Transm. 2010; 117(9): 1111-4.

Spitzer P, Herrmann M, Klafki HW, Smirnov A, Lewczuk P, Kornhuber J, Wiltfang J, Maler JM:

Phagocytosis and LPS alter the maturation state of beta-amyloid precursor protein and induce different Abeta peptide release signatures in human mononuclear phagocytes. J Neuroinflammation. 2010; 7(1): 59. 

Spitzer P, Klafki HW, Blennow K, Buée L, Esselmann H, Herruka SK, Jimenez C, Klivenyi P, Lewczuk P, Maler JM, Markus K, Meyer HE, Morris C, Müller T, Otto M, Parnetti L, Soininen H, Schraen S, Teunissen C, Vecsei L, Zetterberg H, Wiltfang J:

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases. Int J Alzheimers Dis. 2010; Artikel ID 548145.

Striepens N, Scheef L, Wind A, Popp J, Spottke A, Cooper-Mahkorn D, Suliman H, Wagner M, Schild HH, Jessen F:

Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatr Cogn Disord. 2010; 29(1): 75-81.

nach oben

-T-

Teipel SJ, Bokde AL, Meindl T, Amaro E Jr, Soldner J, Reiser MF, Herpertz SC, Möller HJ, Hampel H:

White matter microstructure underlying default mode network connectivity in the human brain. Neuroimage. 2010; 49(3): 2021-32.

Teipel SJ, Ewers M, Wolf S, Jessen F, Kölsch H, Arlt S, Luckhaus C, Schönknecht P, Schmidtke K, Heuser I, Frölich L, Ende G, Pantel J, Wiltfang J, Rakebrandt F, Peters O, Born C, Kornhuber J, Hampel H:

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res. 2010; 182(3): 244-50.

Teipel SJ, Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF, Möller HJ, Heinsen H, Hampel H:

The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study. Hum Brain Mapp. 2010; Epub ahead of print

Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein KH, Filippi M, Ernemann U, Reiser MF, Hampel H:

Longitudinal Changes in Fiber Tract Integrity in Healthy Aging and Mild Cognitive Impairment: A DTI Follow-Up Study. J Alzheimers Dis. 2010; Epub ahead of print

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM:

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

 Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2010; 6(3): 230-8.

Tsolaki M, Papaliagkas V, Anogianakis G, Bernabei R, Emre M, Frölich L, Visser PJ, Michel JP, Pirttila T, Olde Rikkert M, Soininen H, Sobow T, Vellas B, Verhey F, Winblad B; European Alzheimer Disease Consortium:

Consensus statement on dementia education and training in Europe. J Nutr Health Aging. 2010; 14(2): 131-5.

nach oben

-V-

Vieira SI, Rebelo S, Esselmann H, Wiltfang J, Lah J, Lane R, Small SA, Gandy S, da Cruz E Silva EF, da Cruz E Silva OA:

Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener. 2010; 5(1): 40.

nach oben

-W-

Winblad B, Giacobini E, Frölich L, Friedhoff LT, Bruinsma G, Becker RE, Greig NH:

Phenserine Efficacy in Alzheimer's Disease. J Alzheimers Dis. 2010; Epub ahead of print

nach oben
nach oben